The returnee team successfully developed the linear motor module gene sequencing platform. In April, while many industries were hit hard by the new coronavirus and were on a semi shutdown, Xunminkang Biotechnology Co Ltd raised ten million RMB in series a financing, investment by Xi ran capital, Qingtong capital as financial adviser. 

     It is reported that Xunminkang Biotechnology Co. , Ltd. will use this round of financing for new product research and development, the establishment of new technology platform and existing product optimization and promotion. 

     In such a special period, Xunminkang is still favored by investment companies, and certainly many people want to know what kind of company Xunminkang is. It is understood that Xunminkang was founded in 2014, is A HIGH-TECH ENTERPRISE FOUNDED BY AMERICAN MOLECULAR DIAGNOSTIC EXPERTS, focusing on rapid molecular diagnostic technology development of infectious diseases, to provide accurate diagnosis of infectious diseases solutions. Since its establishment, Xunminkang has successfully developed the IngeniSeq clinical microbial metagenomic sequencing technology platform, established a database covering 20,343 species of bacteria, fungi, viruses, parasites and other clinical microorganisms, and set up a Shengxin analysis system。 

    when it comes to gene sequencing equipment, linear motor module is closely related to it. Because of its high precision, high speed, high stability and low noise, linear motor module is widely used in gene sequencing equipment as a driving device. 

      The high precision linear motor module developed and produced by Kunshan is highly praised by all walks of life, among which the typical applications are wafer testing, semiconductor package, lithium ion battery lamination, spraying and so on. 

     The article was originally written by www.tmmotion.com in Kunshan, China. Please quote the source.